Cue Biopharma, Inc.

NASDAQ:CUE

1.22 (USD) • At close January 14, 2025
Bedrijfsnaam Cue Biopharma, Inc.
Symbool CUE
Munteenheid USD
Prijs 1.22
Beurswaarde 77,287,366
Dividendpercentage 0%
52-weken bereik 0.45 - 3.03
Industrie Biotechnology
Sector Healthcare
CEO Mr. Daniel R. Passeri J.D., M.Sc., MSc.
Website https://www.cuebiopharma.com

An error occurred while fetching data.

Over Cue Biopharma, Inc.

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to

Vergelijkbare Aandelen

Gamida Cell Ltd. logo

Gamida Cell Ltd.

GMDA

0.033 USD

CorMedix Inc. logo

CorMedix Inc.

CRMD

11.22 USD

Gritstone bio, Inc. logo

Gritstone bio, Inc.

GRTS

0.032 USD

ORIC Pharmaceuticals, Inc. logo

ORIC Pharmaceuticals, Inc.

ORIC

9.91 USD

Apyx Medical Corporation logo

Apyx Medical Corporation

APYX

1.43 USD

Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc.

OVID

0.757 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)